OMALIZUMAB-BASED TREATMENT OF TEENAGERS, SUFFERING FROM SEVERE ATOPIC BRONCHIAL ASTHMA
Omalizumab, a medicine of the recombinant humanized mono clonal antibodies to Ige, is applied in russia among teenagers throughout a year. it is prescribed to patients with severe persistent incontrolled by iks atopic bronchial asthma (BA). The article generalizes the experience of omalizumab applic...
Saved in:
Main Authors: | T.V. Kulichenko, R.M. Torshkhoeva, L.S. Namazova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Union of pediatricians of Russia
2008-11-01
|
Series: | Педиатрическая фармакология |
Online Access: | https://www.pedpharma.ru/jour/article/view/805 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OMALIZUMAB FOR CHILDREN WITH BRONCHIAL ASTHMA: INDICATIONS TO APPLICATION
by: T.V. Kulichenko
Published: (2007-12-01) -
OMALIZUMAB: EXPANDED OPPORTUNITIES FOR THE ATOPIC DISEASES TREATMENT
by: T.V. Kulichenko
Published: (2009-06-01) -
PHARMACOECONOMIC ASPECT OF OMALIZUMAB APPLICATION AMONG THE PATIENTS, SUFFERING FROM THE BRONCHIAL ASTHMA
by: A.S. Kolbin, et al.
Published: (2008-07-01) -
ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES
by: V. S. Krysanova, et al.
Published: (2021-08-01) -
OMALIZUMAB IN TREATMENT FOR ALLERGIES
by: T.V. Kulichenko
Published: (2007-08-01)